The list prices of the popular diabetes medications Ozempic and Mounjaro, which are also used for weight loss, have been increased along with around 900 other brand-name medications in January. The median increase for these drugs was 4.7%, which is slightly lower than previous years but higher than the inflation rate. Novo Nordisk raised the list price of Ozempic by 3.5% to $969, while Eli Lilly increased the list price of Mounjaro by 4.5% to $1,069. These price increases may affect uninsured individuals or those who have not yet reached their annual deductible. However, both companies offer savings cards and patient assistance programs to help reduce out-of-pocket costs for certain individuals. While GLP-1 drugs like Ozempic and Mounjaro are often covered by insurance for diabetes treatment, they are less likely to be covered for weight loss. Efforts are being made to expand insurance coverage for anti-obesity medications. The high cost of medications in general is a significant issue for many Americans, even those with insurance. Some individuals have had to make tough choices and prioritize certain medications due to their high costs. President Joe Biden has made reducing drug costs a key focus of his campaign.
Залишайтеся на зв'язку
Підпишіться на нашу розсилку та отримуйте інформацію про вихід нових статей, інформацію про ексклюзивні знижки та інше
Або підпишіться на наш Telegram, щоб завжди бути в курсі наших новин.